HIV/AIDS prevention, treatment, care and support for people who use drugs and people in prison settings


Project Status: Ongoing

Project Duration: 23/04/2002 - 31/12/2017

Total Budget: US$ 75,500,000


Partners: Multiple Donors

Target Groups:

 Member States

Outline and Objectives

The work of UNODC in the area of HIV and AIDS focuses mainly on moving towards universal access to HIV prevention, treatment, care and support for people who use drugs and for people living and working in prisons and other closed settings. The Office also promotes the integration of effective HIV prevention, treatment, care and support services into work related human trafficking.

UNODC assists member states in reviewing national policies, strategies and legislation and supporting their adaptation, providing comprehensive HIV services, and strengthening monitoring and evaluation. All activities supported by the Office are geared towards strengthening national ownership and building national capacity.

The project is a global programme that specifically addresses one of UNODC's mandate. In this context, country, regional and thematic programmes, where appropriate, all include sections addressing HIV.

This global project aims to expand the capacity of Member States to reduce the spread of HIV/AIDS among injecting drug users in conformity with the established mandates of the UNODC.  The objectives of this project are to:

  1. Identify and develop best practice.
  2. Build capacity at the regional and national level.
  3. Gather data on the negative health and social consequences of drug abuse with specific reference to HIV/AIDS.

Key Achievements

  • Developed in a collaborative inter-agency manner and reached a common understanding among the Member States on what constitutes a Comprehensive Package of HIV services for people who inject drugs.
  • Scaled up significantly the provision of Comprehensive Package HIV services and programmes in several key countries and regions among specific subgroups of drug users and prison populations.
  • Provided first-ever global, regional and country level benchmark data on coverage of core HIV prevention, treatment, and care services for people who inject drugs.
  • Improved coverage of the comprehensive package of services for drug users with a particular focus on removing legal and policy restraints on opioid substitution therapy and needle and syringe programmes in key countries.
  • Strengthened scaling-up HIV services and efforts for anti-stigmatization and social inclusion of drug users.
  • Developed a global guidance document: "HIV prevention, treatment and care in prisons and other closed settings: a comprehensive package of interventions" , aimed at supporting decision makers in ministries of justice, authorities responsible for closed settings and ministries of health, as well as authorities responsible for workplace safety and occupational health, in planning and implementing a response to HIV in closed settings.
  • Developed a global guidance document: "Technical Guide to HIV Prevention, Treatment and Care for Stimulant Users" for use by policymakers and agencies at the national or regional levels whose work has an impact on HIV and AIDS prevention, treatment and care among stimulant users.